Jacobs Levy Equity Management’s LifePoint Health, Inc. LPNT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-40,610
Closed -$2.35M 1132
2017
Q3
$2.35M Sell
40,610
-39,778
-49% -$2.37M 0.05% 407
2017
Q2
$5.4M Sell
80,388
-124,311
-61% -$7.86M 0.12% 227
2017
Q1
$13.4M Sell
204,699
-54,731
-21% -$3.38M 0.27% 114
2016
Q4
$14.7M Buy
259,430
+73,330
+39% +$4.24M 0.28% 107
2016
Q3
$11M Buy
+186,100
New +$11.2M 0.2% 155
2016
Q1
Sell
-7,580
Closed -$556K 1242
2015
Q4
$556K Hold
7,580
0.01% 542
2015
Q3
$537K Buy
7,580
+500
+7% +$40.6K 0.01% 570
2015
Q2
$616K Sell
7,080
-9,200
-57% -$695K 0.01% 538
2015
Q1
$1.2M Hold
16,280
0.02% 444
2014
Q4
$1.17M Buy
+16,280
New +$1.13M 0.02% 474
2014
Q1
Sell
-90,217
Closed -$4.77M 1136
2013
Q4
$4.77M Sell
90,217
-66,303
-42% -$3.33M 0.07% 297
2013
Q3
$7.3M Sell
156,520
-47,340
-23% -$2.27M 0.12% 212
2013
Q2
$9.96M Buy
+203,860
New +$9.77M 0.18% 166

Other funds holding LPNT

Jacobs Levy Equity Management's LPNT Position: Q4 2017 in Review

Jacobs Levy Equity Management sold out of LifePoint Health, Inc. (LPNT) in Q4 2017, closing a stake of 40,610 shares — an estimated $2.35M sold.

Jacobs Levy Equity Management first reported a position in LPNT in Q2 2013 and held it in 13 quarters. The position peaked at $14.7M in Q4 2016. 212 funds tracked by Wall St. Rank hold LPNT as of Q4 2017.

  • Jacobs Levy Equity Management reported no remaining LifePoint Health, Inc. position as of Q4 2017 after selling out during the quarter.
  • Jacobs Levy Equity Management sold 40,610 LifePoint Health, Inc. shares in Q4 2017, an estimated $2.35M.
  • Jacobs Levy Equity Management first reported a position in LifePoint Health, Inc. in Q2 2013 and held it in 13 quarters.
  • Jacobs Levy Equity Management's LifePoint Health, Inc. position peaked at $14.7M in Q4 2016.
  • 212 funds tracked by Wall St. Rank held LifePoint Health, Inc. as of Q4 2017.

Based on Jacobs Levy Equity Management's 13F filing for Q4 2017, filed 13 Feb 2018.